The pharmacy spend increases health systems can expect.
Pharmacy Best Practices
MS is in need of new medications—these could be the future.
Opportunities to lower drug prices, as promised by President Trump’s American Patients First Blueprint, are picking up steam, some progressing more quickly than others.
The stakes have never been higher in reducing readmissions and hospitals are leveraging pharmacists’ expertise and putting them at the forefront of readmission reduction programs
Last year brought a variety of new treatments—and complications—for patients and payers. These five areas that defined 2018 will continue to define the future.
While still largely a new phenomenon, biosimilars are here to stay—and this year will only bring more of them to market.
WalletHub released a study on Highest Drug Use by State to highlight the areas that stand to be most affected. Here are the top 10.
What experts say will be the year’s biggest problems, and what can be done about them.
As pharmaceuticals grow to consume more and more of the healthcare dollar, traditional care models need to change in order to deliver the best healthcare outcomes and real value. Here are five new models on the rise.
With all eyes on drug prices, payers are looking to biosimilar agents to cut costs—and improve patient outcomes.